Tiabenda
Brand names,
Tiabenda
Analogs
Tiabenda
Brand Names Mixture
Tiabenda
Chemical_Formula
C11H16N2O
Tiabenda
RX_link
http://www.rxlist.com/cgi/generic3/tocainide.htm
Tiabenda
fda sheet
Tiabenda
msds (material safety sheet)
Tiabenda
Synthesis Reference
No information avaliable
Tiabenda
Molecular Weight
192.258 g/mol
Tiabenda
Melting Point
246-266 oC
Tiabenda
H2O Solubility
1.07E+004 mg/L
Tiabenda
State
Solid
Tiabenda
LogP
1.308
Tiabenda
Dosage Forms
400 mg and 600 mg tablets for oral administration
Tiabenda
Indication
For the treatment of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening.
Tiabenda
Pharmacology
Tocainide is a primary amine analog of lidocaine with antiarrhythmic properties useful in the treatment of ventricular arrhythmias. Tocainide, like lidocaine, produces dose dependent decreases in sodium and potassium conductance, thereby decreasing the excitability of myocardial cells. In experimental animal models, the dose-related depression of sodium current is more pronounced in ischemic tissue than in normal tissue. Tocainide is a Class I antiarrhythmic compound with electrophysiologic properties in man similar to those of lidocaine, but dissimilar from quinidine, procainamide, and disopyramide.
Tiabenda
Absorption
Following oral administration, the bioavailability approaches 100 percent, and is unaffected by food.
Tiabenda
side effects and Toxicity
The oral LD50 of tocainide was calculated to be about 800 mg/kg in mice, 1000 mg/kg in rats, and 230 mg/kg in guinea pigs; deaths were usually preceded by convulsions.
Tiabenda
Patient Information
Tiabenda
Organisms Affected
Humans and other mammals